Industry Research Reports
Global Crude Heparin Market Research Report 2026
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Crude Heparin Market Size(US$)
CAGR 2026-2032
5.1%
Market Size,2032
USD 5,387
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 3,985 million
Market Forecast in 2032(Value)
US$ 5,387 million
CAGR
5.1%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Crude Heparin market was valued at US$ 3809 million in 2025 and is anticipated to reach US$ 5387 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Crude Heparin competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Hebei Changshan Biochemical. The top five players hold a share about 46%. China is the largest market, which has a share about 56%, followed by North America and Europe, with share 19% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 91%.
This report delivers a comprehensive overview of the global Crude Heparin market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Crude Heparin. The Crude Heparin market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Crude Heparin market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Crude Heparin manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
- Bioiberica
- Shenzhen Hepalink
- Sanofi
- Nanjing King-friend
- Fengrun Biological Technology
- Aspen Oss
- Hebei Changshan Biochemical
- Changzhou Qianhong
- Hepac (Darling Ingredients)
- Huaian MDC Pharmaceutical
- Yantai Dongcheng Biochemicals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pig Intestine Mucosa Heparin
- Bovine Heparin and Others
Segment by Application
- UFH
- LMWH
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Crude Heparin manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Crude Heparin sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Crude Heparin Market Overview
1.1 Product Definition
1.2 Crude Heparin by Type
1.2.1 Global Crude Heparin Market Value by Type: 2025 vs 2032
1.2.2 Pig Intestine Mucosa Heparin
1.2.3 Bovine Heparin and Others
1.3 Crude Heparin by Application
1.3.1 Global Crude Heparin Market Value by Application: 2025 vs 2032
1.3.2 UFH
1.3.3 LMWH
1.4 Global Crude Heparin Market Size Estimates and Forecasts
1.4.1 Global Crude Heparin Revenue 2021–2032
1.4.2 Global Crude Heparin Sales 2021–2032
1.4.3 Global Crude Heparin Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Crude Heparin Market Competition by Manufacturers
2.1 Global Crude Heparin Sales Market Share by Manufacturers (2021–2026)
2.2 Global Crude Heparin Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Crude Heparin Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Crude Heparin, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Crude Heparin, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Crude Heparin, Product Types and Applications
2.7 Global Key Manufacturers of Crude Heparin, Date of Entry into the Industry
2.8 Global Crude Heparin Market Competitive Situation and Trends
2.8.1 Global Crude Heparin Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Crude Heparin Players Market Share by Revenue
2.8.3 Global Crude Heparin Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Crude Heparin Market Scenario by Region
3.1 Global Crude Heparin Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Crude Heparin Sales by Region: 2021–2032
3.2.1 Global Crude Heparin Sales by Region: 2021–2026
3.2.2 Global Crude Heparin Sales by Region: 2027–2032
3.3 Global Crude Heparin Revenue by Region: 2021–2032
3.3.1 Global Crude Heparin Revenue by Region: 2021–2026
3.3.2 Global Crude Heparin Revenue by Region: 2027–2032
3.4 North America Crude Heparin Market Facts & Figures by Country
3.4.1 North America Crude Heparin Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Crude Heparin Sales by Country (2021–2032)
3.4.3 North America Crude Heparin Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Crude Heparin Market Facts & Figures by Country
3.5.1 Europe Crude Heparin Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Crude Heparin Sales by Country (2021–2032)
3.5.3 Europe Crude Heparin Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Crude Heparin Market Facts & Figures by Region
3.6.1 Asia Pacific Crude Heparin Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Crude Heparin Sales by Region (2021–2032)
3.6.3 Asia Pacific Crude Heparin Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Crude Heparin Market Facts & Figures by Country
3.7.1 Latin America Crude Heparin Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Crude Heparin Sales by Country (2021–2032)
3.7.3 Latin America Crude Heparin Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Crude Heparin Market Facts & Figures by Country
3.8.1 Middle East and Africa Crude Heparin Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Crude Heparin Sales by Country (2021–2032)
3.8.3 Middle East and Africa Crude Heparin Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Crude Heparin Sales by Type (2021–2032)
4.1.1 Global Crude Heparin Sales by Type (2021–2026)
4.1.2 Global Crude Heparin Sales by Type (2027–2032)
4.1.3 Global Crude Heparin Sales Market Share by Type (2021–2032)
4.2 Global Crude Heparin Revenue by Type (2021–2032)
4.2.1 Global Crude Heparin Revenue by Type (2021–2026)
4.2.2 Global Crude Heparin Revenue by Type (2027–2032)
4.2.3 Global Crude Heparin Revenue Market Share by Type (2021–2032)
4.3 Global Crude Heparin Price by Type (2021–2032)
5 Segment by Application
5.1 Global Crude Heparin Sales by Application (2021–2032)
5.1.1 Global Crude Heparin Sales by Application (2021–2026)
5.1.2 Global Crude Heparin Sales by Application (2027–2032)
5.1.3 Global Crude Heparin Sales Market Share by Application (2021–2032)
5.2 Global Crude Heparin Revenue by Application (2021–2032)
5.2.1 Global Crude Heparin Revenue by Application (2021–2026)
5.2.2 Global Crude Heparin Revenue by Application (2027–2032)
5.2.3 Global Crude Heparin Revenue Market Share by Application (2021–2032)
5.3 Global Crude Heparin Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Bioiberica
6.1.1 Bioiberica Company Information
6.1.2 Bioiberica Description and Business Overview
6.1.3 Bioiberica Crude Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Bioiberica Crude Heparin Product Portfolio
6.1.5 Bioiberica Recent Developments/Updates
6.2 Shenzhen Hepalink
6.2.1 Shenzhen Hepalink Company Information
6.2.2 Shenzhen Hepalink Description and Business Overview
6.2.3 Shenzhen Hepalink Crude Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Shenzhen Hepalink Crude Heparin Product Portfolio
6.2.5 Shenzhen Hepalink Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Crude Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sanofi Crude Heparin Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Nanjing King-friend
6.4.1 Nanjing King-friend Company Information
6.4.2 Nanjing King-friend Description and Business Overview
6.4.3 Nanjing King-friend Crude Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Nanjing King-friend Crude Heparin Product Portfolio
6.4.5 Nanjing King-friend Recent Developments/Updates
6.5 Fengrun Biological Technology
6.5.1 Fengrun Biological Technology Company Information
6.5.2 Fengrun Biological Technology Description and Business Overview
6.5.3 Fengrun Biological Technology Crude Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Fengrun Biological Technology Crude Heparin Product Portfolio
6.5.5 Fengrun Biological Technology Recent Developments/Updates
6.6 Aspen Oss
6.6.1 Aspen Oss Company Information
6.6.2 Aspen Oss Description and Business Overview
6.6.3 Aspen Oss Crude Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Aspen Oss Crude Heparin Product Portfolio
6.6.5 Aspen Oss Recent Developments/Updates
6.7 Hebei Changshan Biochemical
6.7.1 Hebei Changshan Biochemical Company Information
6.7.2 Hebei Changshan Biochemical Description and Business Overview
6.7.3 Hebei Changshan Biochemical Crude Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hebei Changshan Biochemical Crude Heparin Product Portfolio
6.7.5 Hebei Changshan Biochemical Recent Developments/Updates
6.8 Changzhou Qianhong
6.8.1 Changzhou Qianhong Company Information
6.8.2 Changzhou Qianhong Description and Business Overview
6.8.3 Changzhou Qianhong Crude Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Changzhou Qianhong Crude Heparin Product Portfolio
6.8.5 Changzhou Qianhong Recent Developments/Updates
6.9 Hepac (Darling Ingredients)
6.9.1 Hepac (Darling Ingredients) Company Information
6.9.2 Hepac (Darling Ingredients) Description and Business Overview
6.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hepac (Darling Ingredients) Crude Heparin Product Portfolio
6.9.5 Hepac (Darling Ingredients) Recent Developments/Updates
6.10 Huaian MDC Pharmaceutical
6.10.1 Huaian MDC Pharmaceutical Company Information
6.10.2 Huaian MDC Pharmaceutical Description and Business Overview
6.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Huaian MDC Pharmaceutical Crude Heparin Product Portfolio
6.10.5 Huaian MDC Pharmaceutical Recent Developments/Updates
6.11 Yantai Dongcheng Biochemicals
6.11.1 Yantai Dongcheng Biochemicals Company Information
6.11.2 Yantai Dongcheng Biochemicals Description and Business Overview
6.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Yantai Dongcheng Biochemicals Crude Heparin Product Portfolio
6.11.5 Yantai Dongcheng Biochemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Crude Heparin Industry Chain Analysis
7.2 Crude Heparin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Crude Heparin Production Mode & Process Analysis
7.4 Crude Heparin Sales and Marketing
7.4.1 Crude Heparin Sales Channels
7.4.2 Crude Heparin Distributors
7.5 Crude Heparin Customer Analysis
8 Crude Heparin Market Dynamics
8.1 Crude Heparin Industry Trends
8.2 Crude Heparin Market Drivers
8.3 Crude Heparin Market Challenges
8.4 Crude Heparin Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Table of Figures
List of Tables
Table 1. Global Crude Heparin Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Crude Heparin Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Crude Heparin Market Competitive Situation by Manufacturers in 2025
Table 4. Global Crude Heparin Sales (Tons) of Key Manufacturers (2021–2026)
Table 5. Global Crude Heparin Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Crude Heparin Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Crude Heparin Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Crude Heparin Average Price (US$/Kg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Crude Heparin, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Crude Heparin, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Crude Heparin, Product Types and Applications
Table 12. Global Key Manufacturers of Crude Heparin, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Crude Heparin Companies by Tier (Tier 1, Tier 2, Tier 3), based on Crude Heparin Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Crude Heparin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Crude Heparin Sales by Region (Tons), 2021–2026
Table 18. Global Crude Heparin Sales Market Share by Region (2021–2026)
Table 19. Global Crude Heparin Sales by Region (Tons), 2027–2032
Table 20. Global Crude Heparin Sales Market Share by Region (2027–2032)
Table 21. Global Crude Heparin Revenue by Region (US$ Million), 2021–2026
Table 22. Global Crude Heparin Revenue Market Share by Region (2021–2026)
Table 23. Global Crude Heparin Revenue by Region (US$ Million), 2027–2032
Table 24. Global Crude Heparin Revenue Market Share by Region (2027–2032)
Table 25. North America Crude Heparin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Crude Heparin Sales by Country (Tons), 2021–2026
Table 27. North America Crude Heparin Sales by Country (Tons), 2027–2032
Table 28. North America Crude Heparin Revenue by Country (US$ Million), 2021–2026
Table 29. North America Crude Heparin Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Crude Heparin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Crude Heparin Sales by Country (Tons), 2021–2026
Table 32. Europe Crude Heparin Sales by Country (Tons), 2027–2032
Table 33. Europe Crude Heparin Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Crude Heparin Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Crude Heparin Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Crude Heparin Sales by Region (Tons), 2021–2026
Table 37. Asia Pacific Crude Heparin Sales by Region (Tons), 2027–2032
Table 38. Asia Pacific Crude Heparin Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Crude Heparin Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Crude Heparin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Crude Heparin Sales by Country (Tons), 2021–2026
Table 42. Latin America Crude Heparin Sales by Country (Tons), 2027–2032
Table 43. Latin America Crude Heparin Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Crude Heparin Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Crude Heparin Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Crude Heparin Sales by Country (Tons), 2021–2026
Table 47. Middle East and Africa Crude Heparin Sales by Country (Tons), 2027–2032
Table 48. Middle East and Africa Crude Heparin Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Crude Heparin Revenue by Country (US$ Million), 2027–2032
Table 50. Global Crude Heparin Sales (Tons) by Type (2021–2026)
Table 51. Global Crude Heparin Sales (Tons) by Type (2027–2032)
Table 52. Global Crude Heparin Sales Market Share by Type (2021–2026)
Table 53. Global Crude Heparin Sales Market Share by Type (2027–2032)
Table 54. Global Crude Heparin Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Crude Heparin Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Crude Heparin Revenue Market Share by Type (2021–2026)
Table 57. Global Crude Heparin Revenue Market Share by Type (2027–2032)
Table 58. Global Crude Heparin Price (US$/Kg) by Type (2021–2026)
Table 59. Global Crude Heparin Price (US$/Kg) by Type (2027–2032)
Table 60. Global Crude Heparin Sales (Tons) by Application (2021–2026)
Table 61. Global Crude Heparin Sales (Tons) by Application (2027–2032)
Table 62. Global Crude Heparin Sales Market Share by Application (2021–2026)
Table 63. Global Crude Heparin Sales Market Share by Application (2027–2032)
Table 64. Global Crude Heparin Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Crude Heparin Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Crude Heparin Revenue Market Share by Application (2021–2026)
Table 67. Global Crude Heparin Revenue Market Share by Application (2027–2032)
Table 68. Global Crude Heparin Price (US$/Kg) by Application (2021–2026)
Table 69. Global Crude Heparin Price (US$/Kg) by Application (2027–2032)
Table 70. Bioiberica Company Information
Table 71. Bioiberica Description and Business Overview
Table 72. Bioiberica Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 73. Bioiberica Crude Heparin Product
Table 74. Bioiberica Recent Developments/Updates
Table 75. Shenzhen Hepalink Company Information
Table 76. Shenzhen Hepalink Description and Business Overview
Table 77. Shenzhen Hepalink Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 78. Shenzhen Hepalink Crude Heparin Product
Table 79. Shenzhen Hepalink Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 83. Sanofi Crude Heparin Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Nanjing King-friend Company Information
Table 86. Nanjing King-friend Description and Business Overview
Table 87. Nanjing King-friend Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 88. Nanjing King-friend Crude Heparin Product
Table 89. Nanjing King-friend Recent Developments/Updates
Table 90. Fengrun Biological Technology Company Information
Table 91. Fengrun Biological Technology Description and Business Overview
Table 92. Fengrun Biological Technology Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 93. Fengrun Biological Technology Crude Heparin Product
Table 94. Fengrun Biological Technology Recent Developments/Updates
Table 95. Aspen Oss Company Information
Table 96. Aspen Oss Description and Business Overview
Table 97. Aspen Oss Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 98. Aspen Oss Crude Heparin Product
Table 99. Aspen Oss Recent Developments/Updates
Table 100. Hebei Changshan Biochemical Company Information
Table 101. Hebei Changshan Biochemical Description and Business Overview
Table 102. Hebei Changshan Biochemical Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 103. Hebei Changshan Biochemical Crude Heparin Product
Table 104. Hebei Changshan Biochemical Recent Developments/Updates
Table 105. Changzhou Qianhong Company Information
Table 106. Changzhou Qianhong Description and Business Overview
Table 107. Changzhou Qianhong Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 108. Changzhou Qianhong Crude Heparin Product
Table 109. Changzhou Qianhong Recent Developments/Updates
Table 110. Hepac (Darling Ingredients) Company Information
Table 111. Hepac (Darling Ingredients) Description and Business Overview
Table 112. Hepac (Darling Ingredients) Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 113. Hepac (Darling Ingredients) Crude Heparin Product
Table 114. Hepac (Darling Ingredients) Recent Developments/Updates
Table 115. Huaian MDC Pharmaceutical Company Information
Table 116. Huaian MDC Pharmaceutical Description and Business Overview
Table 117. Huaian MDC Pharmaceutical Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 118. Huaian MDC Pharmaceutical Crude Heparin Product
Table 119. Huaian MDC Pharmaceutical Recent Developments/Updates
Table 120. Yantai Dongcheng Biochemicals Company Information
Table 121. Yantai Dongcheng Biochemicals Description and Business Overview
Table 122. Yantai Dongcheng Biochemicals Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg), and Gross Margin (2021–2026)
Table 123. Yantai Dongcheng Biochemicals Crude Heparin Product
Table 124. Yantai Dongcheng Biochemicals Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Crude Heparin Distributors List
Table 128. Crude Heparin Customers List
Table 129. Crude Heparin Market Trends
Table 130. Crude Heparin Market Drivers
Table 131. Crude Heparin Market Challenges
Table 132. Crude Heparin Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Crude Heparin
Figure 2. Global Crude Heparin Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Crude Heparin Market Share by Type: 2025 & 2032
Figure 4. Pig Intestine Mucosa Heparin Product Picture
Figure 5. Bovine Heparin and Others Product Picture
Figure 6. Global Crude Heparin Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Crude Heparin Market Share by Application: 2025 & 2032
Figure 8. UFH
Figure 9. LMWH
Figure 10. Global Crude Heparin Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 11. Global Crude Heparin Market Size (US$ Million), 2021–2032
Figure 12. Global Crude Heparin Sales (Tons), 2021–2032
Figure 13. Global Crude Heparin Average Price (US$/Kg), 2021–2032
Figure 14. Crude Heparin Report Years Considered
Figure 15. Crude Heparin Sales Share by Manufacturers in 2025
Figure 16. Global Crude Heparin Revenue Share by Manufacturers in 2025
Figure 17. Top 5 and Top 10 Global Crude Heparin Players: Market Share by Revenue in Crude Heparin in 2025
Figure 18. Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 19. Global Crude Heparin Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 20. North America Crude Heparin Sales Market Share by Country (2021–2032)
Figure 21. North America Crude Heparin Revenue Market Share by Country (2021–2032)
Figure 22. United States Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 23. Canada Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Europe Crude Heparin Sales Market Share by Country (2021–2032)
Figure 25. Europe Crude Heparin Revenue Market Share by Country (2021–2032)
Figure 26. Germany Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. France Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. U.K. Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. Italy Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Russia Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Asia Pacific Crude Heparin Sales Market Share by Region (2021–2032)
Figure 32. Asia Pacific Crude Heparin Revenue Market Share by Region (2021–2032)
Figure 33. China Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Japan Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. South Korea Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. India Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Australia Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Taiwan Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Indonesia Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Thailand Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Malaysia Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Philippines Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Crude Heparin Sales Market Share by Country (2021–2032)
Figure 44. Latin America Crude Heparin Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Crude Heparin Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Crude Heparin Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Crude Heparin Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Crude Heparin by Type (2021–2032)
Figure 54. Global Revenue Market Share of Crude Heparin by Type (2021–2032)
Figure 55. Global Crude Heparin Price (US$/Kg) by Type (2021–2032)
Figure 56. Global Sales Market Share of Crude Heparin by Application (2021–2032)
Figure 57. Global Revenue Market Share of Crude Heparin by Application (2021–2032)
Figure 58. Global Crude Heparin Price (US$/Kg) by Application (2021–2032)
Figure 59. Crude Heparin Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Related Reports
Global Crude Heparin Market Insights, Forecast to 2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-07
Pages: 108
USD 4900.00
(Single User License)
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-16
Pages: 147
USD 5900.00
(Single User License)
Global Crude Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-17
Pages: 159
USD 5600.00
(Single User License)
Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Crude Heparin was estimated to be worth US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 128
USD 3950.00
(Single User License)
Global Crude Heparin Market Research Report 2025
The global market for Crude Heparin was valued at US$ 3640 million in the year 2024 and is projected to reach a revised size of US$ 5148 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-01-18
Pages: 88
USD 2900.00
(Single User License)
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Crude Heparin was estimated to be worth US$ 3640 million and is forecast to reach approximately US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 155
USD 5900.00
(Single User License)
Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Crude Heparin market size was US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 100
USD 4250.00
(Single User License)
Global Crude Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Crude Heparin market is projected to grow from US$ 3640 million in 2024 to US$ 5148 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-10
Pages: 164
USD 4900.00
(Single User License)
Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Crude Heparin was estimated to be worth US$ 3809 million in 2025 and is projected to reach US$ 5387 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 112
USD 3950.00
(Single User License)
Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Crude Heparin market size was US$ 3809 million in 2025 and is forecast to reach a readjusted size of US$ 5387 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 95
USD 4250.00
(Single User License)
Global Crude Heparin Market Insights, Forecast to 2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-07
Pages: 108
USD 4900.00 (Single User License)Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-16
Pages: 147
USD 5900.00 (Single User License)Global Crude Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-17
Pages: 159
USD 5600.00 (Single User License)Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Crude Heparin was estimated to be worth US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 128
USD 3950.00 (Single User License)Global Crude Heparin Market Research Report 2025
The global market for Crude Heparin was valued at US$ 3640 million in the year 2024 and is projected to reach a revised size of US$ 5148 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-01-18
Pages: 88
USD 2900.00 (Single User License)Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Crude Heparin was estimated to be worth US$ 3640 million and is forecast to reach approximately US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 155
USD 5900.00 (Single User License)Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Crude Heparin market size was US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 100
USD 4250.00 (Single User License)Global Crude Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Crude Heparin market is projected to grow from US$ 3640 million in 2024 to US$ 5148 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-10
Pages: 164
USD 4900.00 (Single User License)Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Crude Heparin was estimated to be worth US$ 3809 million in 2025 and is projected to reach US$ 5387 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 112
USD 3950.00 (Single User License)Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Crude Heparin market size was US$ 3809 million in 2025 and is forecast to reach a readjusted size of US$ 5387 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 95
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research